|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00348 CHINAHEALTHWISE
Nominal 
0.073 -0.004 (-5.195%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 36,462 | -28.590% | 99,564 | 113,575 | 146,317 | 142,058 |
| Cost of Sales | (31,631) | -8.388% | (66,102) | (76,226) | (86,023) | (88,788) |
| Gross Profit | 4,831 | -70.780% | 33,462 | 37,349 | 60,294 | 53,270 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,119) | -- | 2,309 | (3,146) | (107,790) | (25,406) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (30,336) | -- | (3,292) | (40,028) | (132,059) | (56,401) | |
| Taxation | 1,242 | -- | 686 | (253) | (2,499) | 2,127 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (29,094) | -- | (2,606) | (40,281) | (134,558) | (54,274) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 6,594 | -2.571% | 13,828 | 8,299 | 8,993 | 7,297 |
| Depreciation & Amortisation | 3,199 | 2.961% | 6,406 | 7,170 | 5,615 | 3,304 |
| Directors' Emoluments | -- | -- | 8,749 | 9,091 | 19,061 | 20,161 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -3.780 | -- | -0.340 | -5.230 | -17.460 | -7.040 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.020 | 0.004 | 0.019 | (0.037) |
| NBV per share ($) | (0.065) | -- | (0.027) | (0.024) | 0.006 | 0.180 |
| Remarks: | Real time quote last updated: 01/09/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -29,094 |
| %Change | -- |
| EPS / (LPS) | HKD -0.038 |
| NBV Per Share ($) | HKD -0.065 |